Read More

What’s Going On With Cheetah Net Stock?

Cheetah Net shares are plummeting Tuesday on heavy trading volume and the stock was halted on a circuit breaker to the downside in early trading. According to data from Benzinga Pro, more than 10.3 million shares have already been traded in the session, compared to the stock's 100-day average of 1.311 million shares.

CTNT

Read More

Mangoceuticals Develops Oral GLP-1s: Stock Soars

Mangoceuticals announced the development of proprietary oral formulations of Semaglutide ("Slim") and Tirzepatide ("Trim") to aid in weight management and said it plans to have the products available for customers in the beginning of the 3rd quarter with ‘Slim' and ‘Trim' priced at $299/month and $399/month, respectively.

MGRX

Read More

Palo Alto Networks Shares Drop After Q3 Results, In-Line Guidance: The Details

Palo Alto Networks reported quarterly earnings of $1.32 per share which beat the analyst consensus estimate of $1.25 by 5.6%. Quarterly sales clocked in at $1.985 billion which beat the analyst consensus estimate of $1.967 billion and represents a 15.33% increase over sales of $1.721 billion from the same period last year.

PANW

Read More

What’s Going On With GT Biopharma Stock?

GT Biopharma shares are moving on heavy trading volume despite a lack of company-specific news. The stock is one of the top trending tickers on Stocktwits which may point to a rally led by retail traders. According to data from Benzinga Pro, more than 60.4 million shares have been traded in the session, far exceeding the stock's 100-day average of less than 11,000 shares.

GTBP